Is segmental transarterial yttrium 90 radiation a curative option for solitary hepatocellular carcinoma ≤5 cm?

Authors

  • Olivier Seror M.D., PH.D.,

    1. Hôpital Jean Verdier, Groupe des Hopitaux Universitaires Paris Saint Denis, Assistance Publique Hôpitaux de Paris, Radiology, Bondy, France
    Search for more papers by this author
  • Jean-Charles Nault M.D., PH.D.,

    1. Hôpital Jean Verdier, Groupe des Hopitaux Universitaires Paris Saint Denis, Assistance Publique Hôpitaux de Paris, Radiology, Bondy, France
    Search for more papers by this author
  • Pierre Nahon M.D., PH.D.,

    1. Hôpital Jean Verdier, Groupe des Hopitaux Universitaires Paris Saint Denis, Assistance Publique Hôpitaux de Paris, Radiology, Bondy, France
    Search for more papers by this author
  • Gisele N'Kontchou M.D.,

    1. Hôpital Jean Verdier, Groupe des Hopitaux Universitaires Paris Saint Denis, Assistance Publique Hôpitaux de Paris, Radiology, Bondy, France
    Search for more papers by this author
  • Jean-Claude Trinchet M.D., PH.D.

    1. Hôpital Jean Verdier, Groupe des Hopitaux Universitaires Paris Saint Denis, Assistance Publique Hôpitaux de Paris, Radiology, Bondy, France
    Search for more papers by this author

  • Potential conflict of interest: Dr. Seror consults, advises, and received grants from Olympus Surgical. He consults and received grants from Bayer.

No abstract is available for this article.

Ancillary